Eton Pharmaceuticals (ETON) Invested Capital (2017 - 2025)
Eton Pharmaceuticals' Invested Capital history spans 8 years, with the latest figure at $34.9 million for Q4 2025.
- On a quarterly basis, Invested Capital fell 35.58% to $34.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $34.9 million, a 35.58% decrease, with the full-year FY2025 number at $34.9 million, down 35.58% from a year prior.
- Invested Capital hit $34.9 million in Q4 2025 for Eton Pharmaceuticals, up from $25.9 million in the prior quarter.
- Over the last five years, Invested Capital for ETON hit a ceiling of $54.4 million in Q1 2025 and a floor of $15.5 million in Q4 2023.
- Historically, Invested Capital has averaged $25.1 million across 5 years, with a median of $21.1 million in 2021.
- Biggest five-year swings in Invested Capital: surged 250.45% in 2024 and later plummeted 35.58% in 2025.
- Tracing ETON's Invested Capital over 5 years: stood at $22.9 million in 2021, then fell by 19.35% to $18.5 million in 2022, then dropped by 16.17% to $15.5 million in 2023, then surged by 250.45% to $54.2 million in 2024, then plummeted by 35.58% to $34.9 million in 2025.
- Business Quant data shows Invested Capital for ETON at $34.9 million in Q4 2025, $25.9 million in Q3 2025, and $26.7 million in Q2 2025.